CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
Yu Jin Kim, Jin Woo Lee, Yun Soo Kim, Sook-Hyang Jeong, Young Seok Kim, Hyung Joon Yim, Bo Hyun Kim, Chun Kyon Lee, Choong Kee Park, Sang Hoon Park
Clin Mol Hepatol. 2011;17(3):199-205.   Published online 2011 September 30    DOI: https://doi.org/10.3350/kjhep.2011.17.3.199

Excel Download

Clinical features and treatment efficacy of peginterferon alfa plus ribavirin in chronic hepatitis C patients coinfected with hepatitis B virus
The Korean Journal of Hepatology. 2011;17(3):199   Crossref logo
Link1 Link2 Link3

A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C
Alimentary Pharmacology & Therapeutics. 2003;17(5):687-694   Crossref logo
Link1 Link2 Link3

Treatment of chronic hepatitis C: Efficacy of initial treatment of peginterferon alpha-2a versus peginterferon alpha-2b plus ribavirin in naive chronic hepatitis C patients
The Korean Journal of Hepatology. 2008;14(4):443   Crossref logo
Link1 Link2 Link3

Peginterferon alfa-2a/ribavirin in hepatitis C virus patients nontolerant or nonresponsive to peginterferon alfa-2b/ribavirin
Alimentary Pharmacology & Therapeutics. 2007;27(5):433-440   Crossref logo
Link1 Link2

PGI25 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients
Value in Health. 2012;15(4):A139   Crossref logo
Link1 Link2

PGI24 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Peginterferon Alfa Plus Ribavirin in the Retreatment of Patients with Chronic Hepatitis C Virus Genotype I Infection
Value in Health. 2012;15(4):A139   Crossref logo
Link1 Link2

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
Hepatology. 2002;35(4):930-936   Crossref logo
Link1 Link2 Link3

PGI16 Cost Effectiveness of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Treatment of Chronic Hepatitis C (CHC) in Previously Untreated Genotype I Patients
Value in Health. 2012;15(7):A328   Crossref logo
Link1 Link2

PGI21 Cost Effectiveness of the Combination of Boceprevir Plus Peginterferon Alpha and Ribavirin Versus Telaprevir Plus Peginterferon Alfa and Ribavirin in the Retreatment of Patients With Chronic Hepatitis C Virus Genotype I Infection
Value in Health. 2012;15(7):A329   Crossref logo
Link1 Link2

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
Hepatology. 2003;38(3):645-652   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.